COVID-19 infection leading to acute mesenteric ischemia is presumed to be a COVID-19-associated hypercoagulable state, von Willebrand factor activation, and direct intestinal endothelial damage due to binding of SAR-CoV-2 to angiotensin-converting enzyme 2 in the intestinal cell epithelium. This evidence concerns the gene ACE2 and COVID-19.